A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization
Clinical trial NCT03250377 · COMPLETED
Trial details
- NCT number
- NCT03250377
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-05
- Primary completion
- 2024-12-24
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.